TJP1 and cancer: The fact that Oxy186 also inhibited expression of EMT-inducing transcription factor SNAIL and ZEB1 as well as expression of mesenchymal marker VIM and TJP1 suggests that Oxy186 could be also useful in treating the late stages of cancers, as those cancer cells are poised to undergo EMT, invasion and metastasis.